サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1387032

女性向け健康診断市場レポート：2030年までの動向、予測、競合分析

Womens Health Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

女性向け健康診断市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年10月25日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

女性向け健康診断の動向と予測

世界の女性向け健康診断市場は、2024年から2030年までのCAGRが8.1%で、2030年までに推定488億2,000万米ドルに達すると予想されます。この市場の主な促進要因は、女性における感染症の有病率の高さとPOC検査への適応の拡大です。世界の女性向け健康診断市場の将来は、病院・診療所、診断・画像診断センター、在宅介護の各市場におけるビジネスチャンスで有望視されています。

女性向け健康診断市場の洞察

Lucintelの予測では、乳がんの発生率の高さと、アブスのような高度な乳がん診断技術に対する意識の高まりから、乳がんが予測期間中に最も高い成長を遂げる見込みです。

同市場では、自己検査キットを使用する利点が増加していることから、在宅医療が引き続き最大セグメントとなります。

北米は、女性のがん有病率の増加により、予測期間中に最も高い成長が見込まれています。

本レポートでは、以下の11の主要な質問に回答している：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の女性向け健康診断市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の女性向け健康診断市場の動向（2018-2023）と予測（2024-2030）
  • 最終用途産業別の世界の女性向け健康診断市場
    • 病院とクリニック
    • 診断センターと画像センター
    • 在宅ケア
    • その他
  • 用途別の世界の女性向け健康診断市場
    • 骨粗鬆症検査
    • OVCテスト
    • 子宮頸がん検査
    • 乳がん検査
    • 妊娠と不妊検査
    • 出生前遺伝子スクリーニングと保因者検査
    • 感染症検査
    • 性病検査
    • 超音波検査

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の女性向け健康診断市場
  • 北米の女性向け健康診断市場
  • 欧州の女性向け健康診断市場
  • アジア太平洋地域の女性向け健康診断市場
  • その他地域女性向け健康診断市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 最終用途産業別の世界の女性向け健康診断市場の成長機会
    • 用途別の世界の女性向け健康診断市場の成長機会
    • 地域別の世界の女性向け健康診断市場の成長機会
  • 世界の女性向け健康診断市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の女性向け健康診断市場の能力拡大
    • 世界の女性向け健康診断市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • F. Hoffmann-la Roche
  • Siemens Aktiengesellschaft
  • Quest Diagnostics Incorporated
  • Ge Healthcare
  • Koninklijke Philips
  • General Motors
  • Abbott Laboratories
  • Becton
  • Dickinson
  • Hologic
目次

Womens Health Diagnostic Trends and Forecast

The future of the global womens health diagnostic market looks promising with opportunities in the hospitals & clinics, diagnostic and imaging centers, and home care settings markets. The global womens health diagnostic market is expected to reach an estimated $48.82 billion by 2030 with a CAGR of 8.1% from 2024 to 2030. The major drivers for this market are high prevalence of infectious diseases in women and growing adaption of POC dignostic testing.

A more than 150-page report is developed to help in your business decisions.

Womens Health Diagnostic by Segment

The study includes a forecast for the global womens health diagnostic by end use industry, application, and region.

Womens Health Diagnostic Market by End Use Industry Industry [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Diagnostic & Imaging Centers
  • Home Care Settings
  • Others

Womens Health Diagnostic Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Osteoporosis Testing
  • OVC Testing
  • Cervical Cancer Testing
  • Breast Cancer Testing
  • Pregnancy & Fertility Testing
  • Prenatal Genetic Screening & Carrier Testing
  • Infectious Disease Testing
  • STD Testing
  • Ultrasound Tests
  • Others

Womens Health Diagnostic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Womens Health Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies womens health diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the womens health diagnostic companies profiled in this report include-

  • F. Hoffmann-La Roche
  • Siemens Aktiengesellschaft
  • Quest Diagnostics Incorporated
  • GE Healthcare
  • Koninklijke Philips
  • General Motors
  • Abbott Laboratories
  • Becton
  • Dickinson
  • Hologic

Womens Health Diagnostic Market Insights

Lucintel forecasts that breast cancer is expected to witness highest growth over the forecast period due to high occurrence of breast cancer and rising awareness about advanced breast cancer diagnostic techniques, such as abus.

Within this market, home care settings will remain the largest segment due to increasing advantages of using self-testing kits.

North America is expected to witness highest growth over the forecast period due to increasing prevalence of cancer among women.

Features of the Global Womens Health Diagnostic Market

Market Size Estimates: Womens health diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Womens health diagnostic market size by end use industry, application, and region in terms of value ($B).

Regional Analysis: Womens health diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different end use industry, application, and regions for the womens health diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the womens health diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the womens health diagnostic market size?

Answer: The global womens health diagnostic market is expected to reach an estimated $48.82 billion by 2030.

Q.2 What is the growth forecast for womens health diagnostic market?

Answer: The global womens health diagnostic market is expected to grow with a CAGR of 8.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the womens health diagnostic market?

Answer: The major drivers for this market are high prevalence of infectious diseases in women and growing adaption of POC dignostic testing.

Q4. What are the major segments for womens health diagnostic market?

Answer: The future of the womens health diagnostic market looks promising with opportunities in the hospitals & clinics, diagnostic and imaging centers, and home care settings markets.

Q5. Who are the key womens health diagnostic market companies?

Answer: Some of the key womens health diagnostic companies are as follows:

  • F. Hoffmann-La Roche
  • Siemens Aktiengesellschaft
  • Quest Diagnostics Incorporated
  • Ge Healthcare
  • Koninklijke Philips
  • General Motors
  • Abbott Laboratories
  • Becton
  • Dickinson
  • Hologic

Q6. Which womens health diagnostic market segment will be the largest in future?

Answer: Lucintel forecasts that breast cancer is expected to witness highest growth over the forecast period due to high occurrence of breast cancer and rising awareness about advanced breast cancer diagnostic techniques, such as abus.

Q7. In womens health diagnostic market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to increasing prevalence of cancer among women.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the womens health diagnostic market by end use industry (hospitals & clinics, diagnostic & imaging centers, home care settings, and others), application (osteoporosis testing, ovc testing, cervical cancer testing, breast cancer testing, pregnancy & fertility testing, prenatal genetic screening & carrier testing, infectious disease testing, STD testing, ultrasound tests, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Womens Health Diagnostic Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Womens Health Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Womens Health Diagnostic Market by End Use Industry Industry
    • 3.3.1: Hospitals & Clinics
    • 3.3.2: Diagnostic & Imaging Centers
    • 3.3.3: Home Care Settings
    • 3.3.4: Others
  • 3.4: Global Womens Health Diagnostic Market by Application
    • 3.4.1: osteoporosis testing
    • 3.4.2: OVC testing
    • 3.4.3: cervical cancer testing
    • 3.4.4: breast cancer testing
    • 3.4.5: pregnancy & fertility testing
    • 3.4.6: prenatal genetic screening & carrier testing
    • 3.4.7: infectious disease testing
    • 3.4.8: STD testing
    • 3.4.9: ultrasound tests

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Womens Health Diagnostic Market by Region
  • 4.2: North American Womens Health Diagnostic Market
    • 4.2.2: North American Womens Health Diagnostic Market by Application: osteoporosis testing, OVC testing, cervical cancer testing, breast cancer testing, pregnancy & fertility testing, prenatal genetic screening & carrier testing, infectious disease testing, STD testing, ultrasound tests, and Others
  • 4.3: European Womens Health Diagnostic Market
    • 4.3.1: European Womens Health Diagnostic Market by End Use Industry Industry: Hospitals & Clinics, Diagnostic & Imaging Centers, Home Care Settings, and Others
    • 4.3.2: European Womens Health Diagnostic Market by Application: osteoporosis testing, OVC testing, cervical cancer testing, breast cancer testing, pregnancy & fertility testing, prenatal genetic screening & carrier testing, infectious disease testing, STD testing, ultrasound tests, and Others
  • 4.4: APAC Womens Health Diagnostic Market
    • 4.4.1: APAC Womens Health Diagnostic Market by End Use Industry Industry: Hospitals & Clinics, Diagnostic & Imaging Centers, Home Care Settings, and Others
    • 4.4.2: APAC Womens Health Diagnostic Market by Application: osteoporosis testing, OVC testing, cervical cancer testing, breast cancer testing, pregnancy & fertility testing, prenatal genetic screening & carrier testing, infectious disease testing, STD testing, ultrasound tests, and Others
  • 4.5: ROW Womens Health Diagnostic Market
    • 4.5.1: ROW Womens Health Diagnostic Market by End Use Industry Industry: Hospitals & Clinics, Diagnostic & Imaging Centers, Home Care Settings, and Others
    • 4.5.2: ROW Womens Health Diagnostic Market by Application: osteoporosis testing, OVC testing, cervical cancer testing, breast cancer testing, pregnancy & fertility testing, prenatal genetic screening & carrier testing, infectious disease testing, STD testing, ultrasound tests, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Womens Health Diagnostic Market by End Use Industry Industry
    • 6.1.2: Growth Opportunities for the Global Womens Health Diagnostic Market by Application
    • 6.1.3: Growth Opportunities for the Global Womens Health Diagnostic Market by Region
  • 6.2: Emerging Trends in the Global Womens Health Diagnostic Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Womens Health Diagnostic Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Womens Health Diagnostic Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: F. Hoffmann-la Roche
  • 7.2: Siemens Aktiengesellschaft
  • 7.3: Quest Diagnostics Incorporated
  • 7.4: Ge Healthcare
  • 7.5: Koninklijke Philips
  • 7.6: General Motors
  • 7.7: Abbott Laboratories
  • 7.8: Becton
  • 7.9: Dickinson
  • 7.10: Hologic